Therapeutic Effects of Modified Gengnianchun Formula on Stress-Induced Diminished Ovarian Reserve Based on Experimental Approaches and Network Pharmacology [Erratum]

Abstract

Gao L, Zhang Y, Xu H, Zhao F, Wang W. Drug Des Devel Ther. 2020;14:4975–4992 The authors have advised that there was an error in the author list on page 4975 which was introduced by the Editorial staff during the publication process. The correct author list and affiliations are as follows:Lingyun Gao1,2,*Yang Zhang1,2,*Huangfang Xu2Fangui Zhao2,3Wenjun Wang1,21Department of Integrated Traditional Chinese Medicine and Western Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China; 2Shanghai Key Laboratoryof Female Reproductive Endocrine Related Diseases, Shanghai 200011, People’s Republic of China; 3Department of Ultrasound Diagnosis, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China *These authors contributed equally to this workThere was also an error on page 4990. Acknowledgment section, the acknowledgment “Lingyun Gao and Yang Zhang are joint first authors” was not included by Editorial staff. Read the original article

Keywords

• modified gengnianchun formula
• diminished ovarian reserve
• stress
• follicle development
• network pharmacology
• target gene